Dr. Ali Mouzannar is an Assistant Professor of Urologic Oncology at the Desai Sethi Urology Institute, University of Miami Health System, and Associate Program Director of the SUO-accredited Urologic Oncology Fellowship. He provides comprehensive, multidisciplinary care for prostate, bladder, and kidney cancers, with advanced expertise in robotic and open oncologic surgery. His surgical practice includes radical prostatectomy, partial and radical nephrectomy, radical cystectomy, and retroperitoneal lymph node dissection (RPLND)—delivering durable cancer control while preserving quality of life.
Dr. Mouzannar maintains an active clinical trials program and serves as Principal Investigator on investigator-initiated, cooperative group, and industry-sponsored studies. His research focuses on non–muscle invasive bladder cancer, biomarker-guided therapy selection, and novel intravesical and systemic treatments. He also conducts work exploring how artificial intelligence and machine learning can advance surgical education, performance assessment, and outcomes. His academic contributions include peer-reviewed publications and book chapters, and he serves as a reviewer for scientific journals.
Trained at Memorial Sloan Kettering Cancer Center (urologic oncology fellowship, 2024) following University of Miami urology residency (2022), Dr. Mouzannar integrates evidence-driven care, complex surgical capability, and access to clinical trials—helping patients and referring physicians navigate challenging decisions with clarity and confidence.